Akthelia and University of Iceland lead €6M EU-funded initiative to battle antimicrobial resistance
Akthelia Pharmaceuticals wins €6M EU Horizon grant for IN-ARMOR, a groundbreaking antimicrobial resistance project. Learn how it could change global health today.
FPT Software opens Nanning development center to serve Chinese auto giants and expand nearshore delivery
Vietnam’s FPT Software launches a nearshore delivery center in Nanning to serve Chinese auto majors—discover how this expansion supports its Digital Conglomerate 5.0 vision.
EvoEndo secures AGA investment to scale unsedated transnasal endoscopy technology
Find out how EvoEndo’s unsedated endoscopy platform earned the AGA’s backing—and what it means for the future of GI diagnostics in the U.S.
Masdar takes 50% stake in California’s Big Beau solar-plus-storage project from EDF Renewables
Masdar expands in the U.S. by acquiring 50% of the Big Beau project from EDF Renewables. Find out how this fits into a $20B UAE–US clean energy alliance.
ImmunoGen secures up to $175m from Pharmakon Advisors to accelerate oncology growth
ImmunoGen secures up to $175M in non-dilutive funding from Pharmakon to fuel Elahere’s launch and expand its next-gen ADC pipeline. Read the full breakdown.
MLM Biologics wins defense award to develop device for infection prevention in battlefield wounds
MLM Biologics secures $1.5M from US Army to create a collagen-based wound device for battlefield infections. See how it may soon help civilians too.
Cummins to invest over $1bn across U.S. engine plants to accelerate fuel-agnostic innovation and clean energy transition
Cummins announces over $1 billion investment across U.S. engine plants to advance fuel-agnostic platforms and hydrogen electrolyzer production. Find out what it means for clean energy and American jobs.
Horizon Quantum Computing raises $18.1m in Series A to accelerate software development for quantum era
Find out how Horizon Quantum Computing’s $18.1M Series A is paving the way for quantum programming tools that developers can actually use today.
Narcan nasal spray becomes the first OTC naloxone product approved by the FDA for opioid overdose treatment
Emergent BioSolutions’ Narcan nasal spray is now FDA-approved for over-the-counter use. Find out how this could change the fight against opioid overdoses.
Wolfspeed and NC A&T to build new U.S. R&D center to drive next-gen silicon carbide innovation
Wolfspeed and NC A&T team up to launch a new U.S. R&D center focused on silicon carbide semiconductors. Find out how this could reshape the future of chips.